Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • European Organisation for Research and Treatment of Cancer (EORTC) (Belgium) (1)
  • nct (1)
Country
  • Australia (2)
  • Canada (2)
  • Denmark (2)
  • France (2)
  • Italy (2)
  • Netherlands (2)
  • Sweden (2)
  • Switzerland (2)
  • United Kingdom (2)
  • Belgium (1)
  • Egypt (1)
  • Germany (1)
  • Hungary (1)
  • India (1)
  • Korea, Republic of (1)
  • Mexico (1)
  • New Zealand (1)
  • Norway (1)
  • Poland (1)
  • Portugal (1)
  • Slovakia (1)
  • Slovenia (1)
  • South Africa (1)
  • Spain (1)
  • Venezuela, Bolivarian Republic of (1)
Source
  • isrctn (1)
  • nct (1)
Phase
  • complete (1)
  • ongoing (1)

Country: Netherlands,Denmark,Switzerland,Canada,Sweden,United Kingdom,Australia
nct Update Il y a 5 ans

Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia This study, will compare pregabalin with placebo for the duration of 14 weeks to evaluate the efficacy and safety of pregabalin in patients with fibromyalgia.

  • Country Australia, Canada, Denmark, France, Germany, India, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom, Venezuela, Bolivarian Republic of,
  • organs None
  • Specialty None
Closed trial
More information
European Organisation for Research and Treatment of Cancer (EORTC) (Belgium) Update Il y a 5 ans

Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma (NHL): a phase III randomised clinical trial (Intergroup Collaborative Study) Not provided at time of registration

  • Country Australia, Belgium, Canada, Denmark, Egypt, France, Hungary, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Slovenia, South Africa, Sweden, Switzerland, United Kingdom,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.